REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. Global cancer statistics. 2012. CA Cancer J Clin 2015;65:87-108.

2. Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, et al. Was hypervascular hepatocellular carcinoma visible on previous gadoxetic acid-enhanced magnetic resonance images? Liver Cancer 2015;4:154-62.

3. Tamada T, Korenaga M, Yamamoto A, Higaki A, Kanki A, et al. Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging. Hepatol Res 2017;47:E152-60.

4. Sakamoto M, Effendi K, Masugi Y. Molecular diagnosis of multistage hepatocarcinogenesis. Jpn J Clin Oncol 2010;40:891-6.

5. International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658-64.

6. Torbenson MS, Ng IOL, Park YN, Sakamoto M. Hepatocellular carcinoma. In: edited by the WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. 5th edition. Digestive System Tumours. Lyon, France: International Agency for Research on Cancer; 2019. pp. 229-39.

7. Nakano M, Saito A, Yamamoto M, Doi M, Takasaki K. Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma. Liver 1997;17:41-6.

8. Ueda K, Terada T, Nakanuma Y, Matsui O. .

9. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentogenol 1999;172:969-76.

10. Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology 2009;252:605-14.

11. Ueda K, Matsui O, Kawamori Y, Nakanuma Y, Kadoya M, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 1998;206:161-6.

12. Shinmura R, Matsui O, Kadoya M, Kobayashi S, Terayama N, et al. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2008;18:1918-24.

13. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989;173:123-6.

14. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-25.

15. Shinmura R, Matsui O, Kobayashi S, Terayama N, Sanada J, et al. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 2005;237:512-9.

16. Abu Rmilah A, Zhou W, Nelson E, Lin L, Amiot B, et al. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev Dev Biol 2019;8:e340.

17. Kawamori Y, Matsui O, Kadoya M, Yoshikawa J, Demachi H, et al. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992;183:65-72.

18. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-12.

19. Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Radiology 2010;256:817-26.

20. Kitao A, Matsui O, Yoneda N, Kozaka K, Shinmura R, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 2011;21:2056-66.

21. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 2011;261:834-44.

22. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, et al. Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. Eur J Radiol 2012;81:3002-9.

23. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, et al. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma. J Comput Assist Tomogr 2011;35:181-6.